1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
The biopharmaceutical industry is experiencing rapid transformation as cutting-edge molecular science, digital platforms, and regulatory alignment redefine the global competitive landscape. Senior executives now face new complexities and opportunities, requiring strategic agility and data-driven decision-making at every stage of the value chain.
Market Snapshot
The biopharmaceutical market is entering a pivotal growth phase, propelled by the convergence of advanced digital technologies, innovative therapeutic modalities, and evolving global regulations. Increasing adoption of artificial intelligence and machine learning enhances target identification and accelerates development pipelines. Meanwhile, personalized medicine is shifting the industry from standardized approaches to tailored treatments. This changing paradigm challenges traditional supply chains and operational models while opening new routes to clinical and commercial excellence.
Scope & Segmentation
This report provides a comprehensive analysis across all major biopharmaceutical segments and regional markets. Coverage includes:
- Therapeutic Area: Cardiovascular, Immunology, Infectious Diseases, Neurology, Oncology, Rare Diseases
- Molecule Type: Cell and Gene Therapy, Monoclonal Antibody, Oligonucleotide, Recombinant Protein, Small Molecule, Vaccine
- Route of Administration: Inhalation, Oral, Parenteral, Topical
- Product Type: Biosimilar, Branded, Generic
- Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
- End User: Clinic, Home Healthcare, Hospital
- Technology Platform: Antisense Therapy, Cell Therapy, Gene Editing, mRNA, Peptide Therapy
- Geographic Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), EMEA (including United Kingdom, Germany, France, and others), and Asia-Pacific (China, India, Japan, Australia, South Korea, and additional significant markets)
- Company Profiles: Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, IQVIA Holdings, Inc., Lonza Group AG, Syneos Health, Inc., Catalent, Inc., ICON plc, WuXi AppTec Co., Ltd., Samsung Biologics Co., Ltd., Charles River Laboratories International, Inc.
Key Takeaways
- The integration of real-time analytics and advanced digital ecosystems is enabling faster, more informed decisions from R&D through commercialization.
- Personalized medicine is increasing demand for precision therapies, influencing investment and development priorities.
- Operational shifts to decentralized clinical trial models and modular manufacturing are improving scalability and clinical reach.
- Expanding digital supply-chain management tools enhance resilience and optimize logistics flows, particularly for cell and gene therapies.
- Collaborative regional strategies and harmonized regulatory frameworks improve global access and accelerate cross-border innovation.
- Leading organizations are leveraging partnerships—with technology providers and academic institutions—to expand pipeline diversity and commercial impact.
Tariff Impact
Beginning in 2025, new United States tariff measures have created complex challenges for biopharmaceutical supply chains. Import levies on key raw materials are prompting a shift toward regional manufacturing hubs and supplier diversification to reduce exposure and ensure resilience. In response, companies are revising distribution frameworks, optimizing transportation routes, and investing in advanced tracking and digitized procurement platforms. These adjustments aim to secure continuity, mitigate operational risks, and enhance competitive positioning in a more protectionist trade environment.
Methodology & Data Sources
This research employs a thorough approach integrating secondary data review, financial analysis, and regulatory filings. Targeted primary interviews included senior executives, scientific leaders, and supply-chain professionals. Findings were validated through cross-source triangulation and advanced scenario modeling for reliable, actionable insights.
Why This Report Matters
- Empowers leadership teams with in-depth segmentation analysis and regional intelligence to refine market entry and investment strategies.
- Delivers actionable guidance for navigating regulatory changes, technological advancements, and evolving supply-chain dynamics in the biopharmaceutical sector.
- Supports competitive advantage by identifying growth opportunities and operational best practices amid ongoing industry transformation.
Conclusion
This report outlines the critical trends, operational shifts, and strategic frameworks shaping biopharmaceutical innovation and growth. Senior executives will gain the perspective and tools needed to adapt, invest wisely, and deliver impactful therapeutic solutions across global markets.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of artificial intelligence and machine learning for predictive biomarker discovery across complex disease targets
5.2. Adoption of decentralized clinical trials incorporating wearable sensors and telehealth to improve patient recruitment diversity
5.3. Expansion of mRNA vaccine platforms into oncology and rare disease therapeutic development pipelines
5.4. Strategic collaborations between biopharma firms and big tech companies for cloud-native data analytics in R&D scaling
5.5. Advancements in gene editing modalities such as base editing and prime editing for inherited disease correction strategies
5.6. Increasing market penetration of next generation antibody-drug conjugates with optimized payload and linker technologies
5.7. Utilization of digital twin models to simulate patient-specific pharmacokinetics and optimize dosing regimens in silico
5.8. Growing focus on microbiome modulation therapies and gut-brain axis interventions for neurodegenerative disease management
5.9. Leveraging real-world evidence and patient-reported outcomes to drive market access and reimbursement negotiations
5.2. Adoption of decentralized clinical trials incorporating wearable sensors and telehealth to improve patient recruitment diversity
5.3. Expansion of mRNA vaccine platforms into oncology and rare disease therapeutic development pipelines
5.4. Strategic collaborations between biopharma firms and big tech companies for cloud-native data analytics in R&D scaling
5.5. Advancements in gene editing modalities such as base editing and prime editing for inherited disease correction strategies
5.6. Increasing market penetration of next generation antibody-drug conjugates with optimized payload and linker technologies
5.7. Utilization of digital twin models to simulate patient-specific pharmacokinetics and optimize dosing regimens in silico
5.8. Growing focus on microbiome modulation therapies and gut-brain axis interventions for neurodegenerative disease management
5.9. Leveraging real-world evidence and patient-reported outcomes to drive market access and reimbursement negotiations
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. Biopharmaceutical CXO Market, by Therapeutic Area
8.1. Introduction
8.2. Cardiovascular
8.3. Immunology
8.4. Infectious Diseases
8.5. Neurology
8.6. Oncology
8.7. Rare Diseases
8.2. Cardiovascular
8.3. Immunology
8.4. Infectious Diseases
8.5. Neurology
8.6. Oncology
8.7. Rare Diseases
9. Biopharmaceutical CXO Market, by Molecule Type
9.1. Introduction
9.2. Cell and Gene Therapy
9.3. Monoclonal Antibody
9.4. Oligonucleotide
9.5. Recombinant Protein
9.6. Small Molecule
9.7. Vaccine
9.2. Cell and Gene Therapy
9.3. Monoclonal Antibody
9.4. Oligonucleotide
9.5. Recombinant Protein
9.6. Small Molecule
9.7. Vaccine
10. Biopharmaceutical CXO Market, by Route of Administration
10.1. Introduction
10.2. Inhalation
10.3. Oral
10.4. Parenteral
10.5. Topical
10.2. Inhalation
10.3. Oral
10.4. Parenteral
10.5. Topical
11. Biopharmaceutical CXO Market, by Product Type
11.1. Introduction
11.2. Biosimilar
11.3. Branded
11.4. Generic
11.2. Biosimilar
11.3. Branded
11.4. Generic
12. Biopharmaceutical CXO Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.4. Retail Pharmacy
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.4. Retail Pharmacy
13. Biopharmaceutical CXO Market, by End User
13.1. Introduction
13.2. Clinic
13.3. Home Healthcare
13.4. Hospital
13.2. Clinic
13.3. Home Healthcare
13.4. Hospital
14. Biopharmaceutical CXO Market, by Technology Platform
14.1. Introduction
14.2. Antisense Therapy
14.3. Cell Therapy
14.4. Gene Editing
14.5. MRNA
14.6. Peptide Therapy
14.2. Antisense Therapy
14.3. Cell Therapy
14.4. Gene Editing
14.5. MRNA
14.6. Peptide Therapy
15. Americas Biopharmaceutical CXO Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Biopharmaceutical CXO Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Biopharmaceutical CXO Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Thermo Fisher Scientific Inc.
18.3.2. Laboratory Corporation of America Holdings
18.3.3. IQVIA Holdings, Inc.
18.3.4. Lonza Group AG
18.3.5. Syneos Health, Inc.
18.3.6. Catalent, Inc.
18.3.7. ICON plc
18.3.8. WuXi AppTec Co., Ltd.
18.3.9. Samsung Biologics Co., Ltd.
18.3.10. Charles River Laboratories International, Inc.
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Thermo Fisher Scientific Inc.
18.3.2. Laboratory Corporation of America Holdings
18.3.3. IQVIA Holdings, Inc.
18.3.4. Lonza Group AG
18.3.5. Syneos Health, Inc.
18.3.6. Catalent, Inc.
18.3.7. ICON plc
18.3.8. WuXi AppTec Co., Ltd.
18.3.9. Samsung Biologics Co., Ltd.
18.3.10. Charles River Laboratories International, Inc.
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. BIOPHARMACEUTICAL CXO MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC BIOPHARMACEUTICAL CXO MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC BIOPHARMACEUTICAL CXO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BIOPHARMACEUTICAL CXO MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BIOPHARMACEUTICAL CXO MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. BIOPHARMACEUTICAL CXO MARKET: RESEARCHAI
FIGURE 30. BIOPHARMACEUTICAL CXO MARKET: RESEARCHSTATISTICS
FIGURE 31. BIOPHARMACEUTICAL CXO MARKET: RESEARCHCONTACTS
FIGURE 32. BIOPHARMACEUTICAL CXO MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC BIOPHARMACEUTICAL CXO MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC BIOPHARMACEUTICAL CXO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BIOPHARMACEUTICAL CXO MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BIOPHARMACEUTICAL CXO MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. BIOPHARMACEUTICAL CXO MARKET: RESEARCHAI
FIGURE 30. BIOPHARMACEUTICAL CXO MARKET: RESEARCHSTATISTICS
FIGURE 31. BIOPHARMACEUTICAL CXO MARKET: RESEARCHCONTACTS
FIGURE 32. BIOPHARMACEUTICAL CXO MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BIOPHARMACEUTICAL CXO MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY RARE DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY CELL AND GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY CELL AND GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY OLIGONUCLEOTIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY OLIGONUCLEOTIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY RECOMBINANT PROTEIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY RECOMBINANT PROTEIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY INHALATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY INHALATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY PARENTERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY BIOSIMILAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY BIOSIMILAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY ANTISENSE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY ANTISENSE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY GENE EDITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY MRNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY MRNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY PEPTIDE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY PEPTIDE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 115. CANADA BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 116. CANADA BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 117. CANADA BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 118. CANADA BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 119. CANADA BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 120. CANADA BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 121. CANADA BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 122. CANADA BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 123. CANADA BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. CANADA BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. CANADA BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. CANADA BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. CANADA BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 128. CANADA BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 129. MEXICO BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 130. MEXICO BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 131. MEXICO BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 132. MEXICO BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 133. MEXICO BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 134. MEXICO BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 135. MEXICO BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 136. MEXICO BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 137. MEXICO BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. MEXICO BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. MEXICO BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. MEXICO BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. MEXICO BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 142. MEXICO BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 201. GERMANY BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 202. GERMANY BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 203. GERMANY BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 204. GERMANY BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 205. GERMANY BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 206. GERMANY BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 207. GERMANY BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 208. GERMANY BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 209. GERMANY BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. GERMANY BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. GERMANY BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. GERMANY BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. GERMANY BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 214. GERMANY BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 215. FRANCE BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 216. FRANCE BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 217. FRANCE BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 218. FRANCE BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 219. FRANCE BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 220. FRANCE BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 221. FRANCE BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. FRANCE BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. FRANCE BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. FRANCE BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. FRANCE BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. FRANCE BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. FRANCE BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 228. FRANCE BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 229. RUSSIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 230. RUSSIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 243. ITALY BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 244. ITALY BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 245. ITALY BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 246. ITALY BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 247. ITALY BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 248. ITALY BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 249. ITALY BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. ITALY BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. ITALY BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. ITALY BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. ITALY BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. ITALY BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. ITALY BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 256. ITALY BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 257. SPAIN BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 258. SPAIN BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 259. SPAIN BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 260. SPAIN BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 261. SPAIN BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 262. SPAIN BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 263. SPAIN BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 264. SPAIN BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 265. SPAIN BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. SPAIN BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. SPAIN BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. SPAIN BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. SPAIN BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 270. SPAIN BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 286. SAUDI ARABIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 287. SAUDI ARABIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 288. SAUDI ARABIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 289. SAUDI ARABIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 290. SAUDI ARABIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 291. SAUDI ARABIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 292. SAUDI ARABIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. SAUDI ARABIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 299. SOUTH AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 300. SOUTH AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 301. SOUTH AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 302. SOUTH AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 303. SOUTH AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 304. SOUTH AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 305. SOUTH AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 306. SOUTH AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 307. SOUTH AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. SOUTH AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. SOUTH AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 312. SOUTH AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 313. DENMARK BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 314. DENMARK BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 315. DENMARK BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 316. DENMARK BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 317. DENMARK BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 318. DENMARK BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 319. DENMARK BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 320. DENMARK BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 321. DENMARK BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 322. DENMARK BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 323. DENMARK BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. DENMARK BIOPHARMACEUTICAL
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY RARE DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY CELL AND GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY CELL AND GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY OLIGONUCLEOTIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY OLIGONUCLEOTIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY RECOMBINANT PROTEIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY RECOMBINANT PROTEIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY INHALATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY INHALATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY PARENTERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY BIOSIMILAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY BIOSIMILAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY ANTISENSE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY ANTISENSE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY GENE EDITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY MRNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY MRNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY PEPTIDE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BIOPHARMACEUTICAL CXO MARKET SIZE, BY PEPTIDE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS BIOPHARMACEUTICAL CXO MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 115. CANADA BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 116. CANADA BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 117. CANADA BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 118. CANADA BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 119. CANADA BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 120. CANADA BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 121. CANADA BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 122. CANADA BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 123. CANADA BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. CANADA BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. CANADA BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. CANADA BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. CANADA BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 128. CANADA BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 129. MEXICO BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 130. MEXICO BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 131. MEXICO BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 132. MEXICO BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 133. MEXICO BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 134. MEXICO BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 135. MEXICO BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 136. MEXICO BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 137. MEXICO BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. MEXICO BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. MEXICO BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. MEXICO BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. MEXICO BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 142. MEXICO BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 201. GERMANY BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 202. GERMANY BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 203. GERMANY BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 204. GERMANY BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 205. GERMANY BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 206. GERMANY BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 207. GERMANY BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 208. GERMANY BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 209. GERMANY BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. GERMANY BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. GERMANY BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. GERMANY BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. GERMANY BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 214. GERMANY BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 215. FRANCE BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 216. FRANCE BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 217. FRANCE BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 218. FRANCE BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 219. FRANCE BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 220. FRANCE BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 221. FRANCE BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. FRANCE BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. FRANCE BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. FRANCE BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. FRANCE BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. FRANCE BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. FRANCE BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 228. FRANCE BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 229. RUSSIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 230. RUSSIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 243. ITALY BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 244. ITALY BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 245. ITALY BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 246. ITALY BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 247. ITALY BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 248. ITALY BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 249. ITALY BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. ITALY BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. ITALY BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. ITALY BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. ITALY BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. ITALY BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. ITALY BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 256. ITALY BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 257. SPAIN BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 258. SPAIN BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 259. SPAIN BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 260. SPAIN BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 261. SPAIN BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 262. SPAIN BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 263. SPAIN BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 264. SPAIN BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 265. SPAIN BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. SPAIN BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. SPAIN BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. SPAIN BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. SPAIN BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 270. SPAIN BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 286. SAUDI ARABIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 287. SAUDI ARABIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 288. SAUDI ARABIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 289. SAUDI ARABIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 290. SAUDI ARABIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 291. SAUDI ARABIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 292. SAUDI ARABIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. SAUDI ARABIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 299. SOUTH AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 300. SOUTH AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 301. SOUTH AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 302. SOUTH AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 303. SOUTH AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 304. SOUTH AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 305. SOUTH AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 306. SOUTH AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 307. SOUTH AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. SOUTH AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. SOUTH AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 312. SOUTH AFRICA BIOPHARMACEUTICAL CXO MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 313. DENMARK BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 314. DENMARK BIOPHARMACEUTICAL CXO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 315. DENMARK BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 316. DENMARK BIOPHARMACEUTICAL CXO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 317. DENMARK BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 318. DENMARK BIOPHARMACEUTICAL CXO MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 319. DENMARK BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 320. DENMARK BIOPHARMACEUTICAL CXO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 321. DENMARK BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 322. DENMARK BIOPHARMACEUTICAL CXO MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 323. DENMARK BIOPHARMACEUTICAL CXO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. DENMARK BIOPHARMACEUTICAL
Samples
LOADING...
Companies Mentioned
The companies profiled in this Biopharmaceutical CXO market report include:- Thermo Fisher Scientific Inc.
- Laboratory Corporation of America Holdings
- IQVIA Holdings, Inc.
- Lonza Group AG
- Syneos Health, Inc.
- Catalent, Inc.
- ICON plc
- WuXi AppTec Co., Ltd.
- Samsung Biologics Co., Ltd.
- Charles River Laboratories International, Inc.
